Evolus Inc buy stratec
Start price
20.05.19
/
50%
€14.97
Target price
24.10.20
€8.00
Performance (%)
-81.26%
End price
24.10.20
€2.81
Summary
This prediction ended on 24.10.20 with a price of €2.81. The BUY prediction by stratec for Evolus Inc performed very badly with a performance of -81.26%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evolus Inc | -1.724% | -1.724% | -47.706% | -18.571% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by stratec for this prediction
In the thread Evolus Inc diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 20.05.2019 der Buy-Einschätzung von klostergang mit dem Kursziel 35$ zu.
Überschrift: Evolus obtained FDA approval for its product Jeuveau to treat patients with glabellar lines.
Es gibt keinen Handelsplatz
Kursziel geändert auf 8,0